Latest Insider Transactions at 89bio, Inc. (ETNB)
This section provides a real-time view of insider transactions for 89bio, Inc. (ETNB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 89bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 89bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
5,352
-2.42%
|
$42,816
$8.46 P/Share
|
|
Sep 09
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,212
-3.04%
|
$25,696
$8.46 P/Share
|
|
Sep 09
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,352
-3.4%
|
$42,816
$8.46 P/Share
|
|
Aug 17
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.66%
|
$8,368
$8.04 P/Share
|
|
Aug 17
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.47%
|
$8,368
$8.04 P/Share
|
|
Aug 17
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-0.73%
|
$6,216
$8.04 P/Share
|
|
Aug 17
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,601
-1.0%
|
$36,808
$8.04 P/Share
|
|
Aug 05
2024
|
Francis Willard Sarena Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Apr 11
2024
|
Ra Capital Management, L.P. |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,408,450
+9.24%
|
$7,042,250
$5.33 P/Share
|
|
Apr 01
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
52,718
-10.3%
|
$527,180
$10.91 P/Share
|
|
Apr 01
2024
|
Rohan Palekar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.66%
|
$25,000
$1.93 P/Share
|
|
Mar 04
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,350,000
+9.8%
|
$20,250,000
$15.35 P/Share
|
|
Feb 26
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,477
-0.91%
|
$44,770
$10.76 P/Share
|
|
Feb 17
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-0.72%
|
$7,002
$9.74 P/Share
|
|
Feb 17
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.47%
|
$9,414
$9.74 P/Share
|
|
Feb 17
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,602
-0.93%
|
$41,418
$9.74 P/Share
|
|
Feb 17
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-0.66%
|
$9,414
$9.74 P/Share
|
|
Feb 09
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,568
-3.22%
|
$28,544
$8.45 P/Share
|
|
Feb 09
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
3,568
-1.57%
|
$28,544
$8.45 P/Share
|
|
Feb 09
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,568
-2.19%
|
$28,544
$8.45 P/Share
|
|
Feb 09
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,670
-2.57%
|
$101,360
$8.45 P/Share
|
|
Feb 05
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,190
-0.52%
|
$10,710
$9.8 P/Share
|
|
Feb 05
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,190
-0.72%
|
$10,710
$9.8 P/Share
|
|
Feb 05
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,068
-1.02%
|
$45,612
$9.8 P/Share
|
|
Feb 05
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-0.8%
|
$8,028
$9.8 P/Share
|
|
Feb 01
2024
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
48,750
+17.62%
|
-
|
|
Feb 01
2024
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,750
+22.89%
|
-
|
|
Feb 01
2024
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+23.12%
|
-
|
|
Feb 01
2024
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,750
+30.36%
|
-
|
|
Jan 05
2024
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,671
-7.73%
|
$106,381
$11.53 P/Share
|
|
Jan 05
2024
|
Harry H Mansbach Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+16.65%
|
-
|
|
Jan 05
2024
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,124
-8.85%
|
$67,364
$11.53 P/Share
|
|
Jan 05
2024
|
Ryan Martins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+17.81%
|
-
|
|
Jan 05
2024
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,511
-7.31%
|
$302,621
$11.53 P/Share
|
|
Jan 05
2024
|
Rohan Palekar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+16.62%
|
-
|
|
Jan 05
2024
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
9,671
-5.12%
|
$106,381
$11.53 P/Share
|
|
Jan 05
2024
|
Quoc Le Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.69%
|
-
|
|
Dec 29
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-14.24%
|
$550,000
$11.2 P/Share
|
|
Dec 29
2023
|
Rohan Palekar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+12.46%
|
$50,000
$1.93 P/Share
|
|
Sep 09
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
4,958
-2.94%
|
$79,328
$16.61 P/Share
|
|
Sep 09
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,074
-3.68%
|
$33,184
$16.61 P/Share
|
|
Sep 09
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,821
-3.67%
|
$61,136
$16.61 P/Share
|
|
Aug 17
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,014
-0.97%
|
$15,210
$15.46 P/Share
|
|
Aug 17
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-1.32%
|
$11,295
$15.46 P/Share
|
|
Aug 17
2023
|
Rohan Palekar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,501
-1.47%
|
$67,515
$15.46 P/Share
|
|
Aug 01
2023
|
Harry H Mansbach Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
577
-0.55%
|
$8,655
$15.64 P/Share
|
|
Aug 01
2023
|
Ryan Martins Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-0.6%
|
$5,190
$15.64 P/Share
|
|
Aug 01
2023
|
Quoc Le Nguyen |
SELL
Payment of exercise price or tax liability
|
Direct |
1,591
-0.47%
|
$23,865
$15.55 P/Share
|
|
Jul 17
2023
|
Kathleen Laporte |
SELL
Open market or private sale
|
Direct |
12,500
-100.0%
|
$225,000
$18.8 P/Share
|
|
Jul 17
2023
|
Kathleen Laporte |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$25,000
$2.64 P/Share
|